VANGUARD RESEARCH GROUP
COME SAY HELLO AT NATCON 2022!
We are looking forward to seeing you face-to-face at the National Council for Behavioral Health NATCON in D.C. April 11-12th!
We will be staffing booth #312 and have lots of information and goodies ready for you!
WEBINAR SERIES 2022
VRG is hosting a series of webinars with topics ranging from the basics of conducting research to specialty clinical topics by our team members and experts. Check the schedule out on page 2 of the newsletter and sign up for any topic that interests you!
THE IMPACT OF COVID-19 ON LAI USE
A roundtable discussion on the importance of an integrated collaborative-care approach https://rdcu.be/cJOKZ
VRG’S NEW LOOK!
We have updated our website and given it a fresh look!
Explore it here: www.vanguardresearchgroup.com
EXCITING STUDY RESULTS
Thank you to all those who participated in the Enlighten study. We are very excited to see the positive results! Topline-enlighten-early-results
VRG INVITES YOU TO JOIN OUR NEW FUTURE STUDIES
A STUDY INVOLVING AN FDA-APPROVED MEDICATION + DIGITAL APP FOR ADJUNCTIVE TREATMENT OF MDD.
A NOVEL PHARMACOLOGICAL TREATMENT FOR ACUTE AGITATION IN SCHIZOPHRENIA / BIPOLAR DISORDER FOR USE IN CRISIS STABILIZATION UNITS / PSYCH ER.
AN APP TRACKING HEALTH MEASURES TO ADIVSE CLINICAL CARE IN MOOD DISORDERS AND PSYCHOSIS.
TESTING A NEW THERAPY APP PROVIDING TREATMENT FOR MDD
If you are interested in learning more or participating, please email Marta Hauser at email@example.com.
FOLLOW US ON SOCIAL MEDIA